PeopleBio, Inc. (KOSDAQ: 304840)
South Korea
· Delayed Price · Currency is KRW 3,160.00
-90.00 (-2.77%)
Dec 19, 2024, 2:34 PM KST
PeopleBio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -12,313 | -16,035 | -14,303 | -4,697 | -4,383 |
| Depreciation & Amortization | 1,684 | 1,565 | 1,282 | 734.08 | 284.48 |
| Loss (Gain) From Sale of Assets | - | - | -17.65 | -5.17 | -6.9 |
| Loss (Gain) From Sale of Investments | 288.75 | 395.43 | - | - | - |
| Loss (Gain) on Equity Investments | 916.85 | 934.89 | 835.96 | 380.5 | - |
| Stock-Based Compensation | - | - | - | - | 325.61 |
| Provision & Write-off of Bad Debts | - | - | - | - | 275 |
| Other Operating Activities | -1,084 | 61.43 | 2,299 | -2,450 | 207.43 |
| Change in Accounts Receivable | -690.91 | -1,502 | -1,553 | 179.63 | -33.31 |
| Change in Inventory | -248.78 | -1,877 | -214 | -156.09 | -117.51 |
| Change in Accounts Payable | 20.93 | -156.63 | 259.4 | -157.08 | 105.98 |
| Change in Other Net Operating Assets | -1,499 | 331.87 | -2,563 | -661.94 | -151.57 |
| Operating Cash Flow | -12,924 | -16,282 | -13,975 | -6,833 | -3,494 |
| Capital Expenditures | -341.1 | -719.15 | -1,267 | -1,355 | -157.99 |
| Sale of Property, Plant & Equipment | - | - | 33.25 | 29 | 29 |
| Cash Acquisitions | - | - | - | 25.73 | - |
| Sale (Purchase) of Intangibles | -29.48 | -41.08 | -73.12 | -35.3 | -47.35 |
| Investment in Securities | -3,094 | 2,967 | -10,300 | -2,415 | -282.21 |
| Other Investing Activities | -281.32 | -890.93 | 64.94 | -217.79 | 8.65 |
| Investing Cash Flow | -3,746 | 1,316 | -11,542 | -3,968 | -449.9 |
| Long-Term Debt Issued | - | - | - | 31,000 | - |
| Long-Term Debt Repaid | - | -27,048 | -684.16 | -1,333 | -143.97 |
| Net Debt Issued (Repaid) | -7,031 | -27,048 | -684.16 | 29,667 | -143.97 |
| Issuance of Common Stock | 24,206 | 29,606 | 1,036 | 12,992 | 10,155 |
| Repurchase of Common Stock | -26.02 | -26.02 | - | - | - |
| Other Financing Activities | -518.45 | -518.45 | -1.75 | 691.99 | - |
| Financing Cash Flow | 16,631 | 2,014 | 350.08 | 43,351 | 10,011 |
| Miscellaneous Cash Flow Adjustments | 0 | 0 | - | - | - |
| Net Cash Flow | -39.13 | -12,952 | -25,166 | 32,550 | 6,067 |
| Free Cash Flow | -13,265 | -17,001 | -15,242 | -8,188 | -3,652 |
| Free Cash Flow Margin | -303.38% | -381.80% | -342.91% | -1418.84% | -719.10% |
| Free Cash Flow Per Share | -618.66 | -1025.76 | -1041.91 | -510.46 | -300.93 |
| Cash Interest Paid | 232.22 | 251.37 | 206.88 | 106.75 | 24.83 |
| Cash Income Tax Paid | - | -16.06 | 54.65 | 5.68 | -7.35 |
| Levered Free Cash Flow | -13,778 | -28,889 | -13,378 | 9,824 | - |
| Unlevered Free Cash Flow | -13,535 | -27,390 | -11,516 | 10,532 | - |
| Change in Net Working Capital | 6,718 | 18,664 | 4,147 | -15,711 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.